Market uptake of orphan drugs - a European analysis-Reference-Cited by-同舟云学术

Market uptake of orphan drugs - a European analysis

Published:2012-06-26 Issue:6 Volume:37 Page:664-667
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:

Author:

Picavet E.,Annemans L.,Cleemput I.,Cassiman D.,Simoens S.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.2012.01364.x/fullpdf

Reference25 articles.

1. Regulation (EC) No 141/2000 of the European Parliament and the Council of 16 December 1999 on orphan medicinal products;European Commission;Official J Eur Communities,2000

2. Charter of fundamental rights of the European Union;The European Parliament;Official J Eur Communities,2000

3. European Commission Register of designated orphan medicinal products 2012 http://ec.europa.eu/health/documents/community-register/html/orphreg.htm

4. Why rare diseases are an important medical and social issue;Schieppati;Lancet,2008

5. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products;European Commission;Official J Eur Communities,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Literature Review on Health Emigration in Rare Diseases—A Machine Learning Perspective;International Journal of Environmental Research and Public Health;2023-01-30

2. Prices of new medicines: International analysis and policy options;Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen;2022-12

3. Rare disease patients’ needs: an up-to-date analysis and future directions;Pharmacia;2021-10-06

4. How to Value Orphan Drugs? A Review of European Value Assessment Frameworks;Frontiers in Pharmacology;2021-05-12

5. Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis;Value in Health;2020-12